SBK Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-42
Closed -$3.23K – 218
2026
Q1
$3.23K Buy
+42
New +$3.28K ﹤0.01% 268

Other funds holding ANIP

SBK Financial's ANIP Position: Q2 2026 in Review

SBK Financial sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 42 shares — an estimated $3.23K sold.

SBK Financial first reported a position in ANIP in Q1 2026 and held it in 1 quarter. The position peaked at $3.23K in Q1 2026. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • SBK Financial reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SBK Financial sold 42 ANI Pharmaceuticals shares in Q2 2026, an estimated $3.23K.
  • SBK Financial first reported a position in ANI Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • SBK Financial's ANI Pharmaceuticals position peaked at $3.23K in Q1 2026.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on SBK Financial's 13F filing for Q2 2026, filed 2 Nov 2026.